Quote

We don't argue if drug companies create drugs that can cure humans and charge lots of money for them, even though we all have these diseases. It will be pretty hard to make a different argument for genes.

We're finally moving out of the realm of solely discussing biology in regards to a drug-based world.

To develop drugs for people, we basically dismantle the system. In the lab, we look at things the size of a cell or two. We dismantle life into very small models.

If genetic research doesn't seemed to have lived up to its therapeutic promise, it's because sequencing is just too slow and expensive.

Would-be drug companies must either produce medicines that stand up to federal scrutiny, demonstrate that their data has value to other companies, or go out of business.

I agree, the world would be a better place if doctors were less enthusiastic about adopting very new drugs.

The fact is that proprietary databases don't work for such basic and broadly needed information as the sequence of the human genome.

The overall view of the human genome project has been one of great excitement and positive press, but there are people who have concerns that are quite reasonable, and they are frightened of things they don't understand.

What we do in the laboratory is we try to design drugs that will not just eradicate cancer cells but will eradicate their homes.